Understanding the underlying factors and mechanisms involved in regulating cell-mediated protection by CD4+ T cells from FRT will contribute to the foundation of information essential for developing therapeutic tools to protect women against gynecological cancers and sexually transmitted infections as they age in the years following menopause. This evidence concerns the gene CD4 and female reproductive organ cancer.